Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - STAAR Surgical Company (NasdaqNM:STAA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug  9Conference call: STAAR Surgical Earnings (Q2 2001)
Aug  9Earnings Announcement
Location
1911 Walker Avenue
Monrovia, CA 91016
Phone: (626) 303-7902
Fax: (626) 303-2962
Email: exeoffices@staar.com
Employees (last reported count): 334
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 37%
·Over the last 6 months:
 · one insider buy; 4,000  shares
 · one insider sell; 15.0K shares
  (0.2% of insider shares)
·Institutional: 55% (87% of float)
(90 institutions)
·Net Inst. Selling: 994.0K shares (+11.90%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
STAAR Surgical Company is a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. The Company's products serve the Refractive Vision Correction, Cataract Treatment, and Glaucoma Treatment segments of the ophthalmic market. The Company's products are designed to improve treatment results, minimize patient risk and discomfort and, where possible, simplify ophthalmic procedures for the surgeon and the patient. The Company sells its products worldwide, principally to ophthalmologists, surgical centers, hospitals, managed care providers, health maintenance organizations and group purchasing organizations.
More from Market Guide: Expanded Business Description

Financial Summary
STAAR Surgical Company develops, manufactures and distributes foldable intraocular lenses, and medical devices used in connection with cataract surgery. For the six months ended 6/29/01, total revenues fell 4% to $25.9 million. Net loss fell 76% to $4.4 million. Revenues reflect unfavorable exchange rates and lower IOLs sales. Lower loss reflects the absence of a $13.8 million restructuring charge and a $4.7 million equity loss of joint venture.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

David Bailey, 45
Chairman, Pres, CEO
$308K
John Santos, 45
CFO
192K
Gunther Roepstorff, 55
Exec. VP, Sales--International
240K
Richard Simmons
Sr. VP, Global Operations and Pres, STAAR Surgical AG
--  
Michael Chandler, 56
VP, Manufacturing
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:STAAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 18-Apr-2001
$2.00 
Recent Price$3.32 
52-Week High
on 2-Oct-2000
$18.875
Beta0.56 
Daily Volume (3-month avg)67.8K
Daily Volume (10-day avg)36.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-80.3%
52-Week Change
relative to S&P500
-73.5%
Share-Related Items
Market Capitalization$56.5M
Shares Outstanding17.0M
Float10.7M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$3.17 
Earnings (ttm)-$0.29 
Earnings (mrq)-$0.25 
Sales (ttm)$3.19 
Cash (mrq*)$0.23 
Valuation Ratios
Price/Book (mrq*)1.05 
Price/EarningsN/A 
Price/Sales (ttm)1.04 
Income Statements
Sales (ttm)$53.3M
EBITDA (ttm*)-$3.33M
Income available to common (ttm)-$5.06M
Profitability
Profit Margin (ttm)-9.3%
Operating Margin (ttm)-12.5%
Fiscal Year
Fiscal Year EndsDec 29
Most recent quarter
(fully updated)
29-June-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-6.05%
Return on Equity (ttm)-9.64%
Financial Strength
Current Ratio (mrq*)1.79 
Debt/Equity (mrq*)0.18 
Total Cash (mrq)$3.95M
Short Interest
As of 8-Aug-2001
Shares Short31.0K
Percent of Float0.3%
Shares Short
(Prior Month)
31.0K
Short Ratio0.61 
Daily Volume51.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 29-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.